Parkman Healthcare Partners’s Dentsply Sirona XRAY Stock Holding History

Parkman Healthcare Partners’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-73,566	Closed	-$4.1M	–	96
2021 Q4	$4.1M	Sell	73,566 -6,889	-9%	-$379K	0.91%	34
2021 Q3	$4.67M	Sell	80,455 -30,000	-27%	-$1.85M	1.18%	27
2021 Q2	$6.99M	Buy	110,455 +60,455	+121%	+$3.98M	1.53%	22
2021 Q1	$3.19M	Buy	+50,000	New	+$2.9M	0.74%	43

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Parkman Healthcare Partners's XRAY Position: Q1 2022 in Review

Parkman Healthcare Partners sold out of Dentsply Sirona (XRAY) in Q1 2022, closing a stake of 73,566 shares — an estimated $4.1M sold.

Parkman Healthcare Partners first reported a position in XRAY in Q1 2021 and held it in 4 quarters. The position peaked at $6.99M in Q2 2021. 537 funds tracked by Wall St. Rank hold XRAY as of Q1 2022.

Parkman Healthcare Partners reported no remaining Dentsply Sirona position as of Q1 2022 after selling out during the quarter.
Parkman Healthcare Partners sold 73,566 Dentsply Sirona shares in Q1 2022, an estimated $4.1M.
Parkman Healthcare Partners first reported a position in Dentsply Sirona in Q1 2021 and held it in 4 quarters.
Parkman Healthcare Partners's Dentsply Sirona position peaked at $6.99M in Q2 2021.
537 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2022.

Based on Parkman Healthcare Partners's 13F filing for Q1 2022, filed 13 May 2022.